722 related articles for article (PubMed ID: 16176115)
21. When special populations intersect with drug-drug interactions: Application of physiologically-based pharmacokinetic modeling in pregnant populations.
Sychterz C; Galetin A; Taskar KS
Biopharm Drug Dispos; 2021 Apr; 42(4):160-177. PubMed ID: 33759451
[TBL] [Abstract][Full Text] [Related]
22. Principles and clinical application of assessing alterations in renal elimination pathways.
Tett SE; Kirkpatrick CM; Gross AS; McLachlan AJ
Clin Pharmacokinet; 2003; 42(14):1193-211. PubMed ID: 14606929
[TBL] [Abstract][Full Text] [Related]
23. Clinical pharmacokinetics of fluvastatin.
Scripture CD; Pieper JA
Clin Pharmacokinet; 2001; 40(4):263-81. PubMed ID: 11368292
[TBL] [Abstract][Full Text] [Related]
24. The Effects of CKD on Cytochrome P450-Mediated Drug Metabolism.
Ladda MA; Goralski KB
Adv Chronic Kidney Dis; 2016 Mar; 23(2):67-75. PubMed ID: 26979145
[TBL] [Abstract][Full Text] [Related]
25. Effects of water deprivation on drug pharmacokinetics: correlation between drug metabolism and hepatic CYP isozymes.
Lee JH; Oh JM; Lee MG
Arch Pharm Res; 2008 Aug; 31(8):951-64. PubMed ID: 18787780
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of 5-fluorouracil on human cytochrome P(450) isoforms in human liver microsomes.
Park JY; Kim KA
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):407-9. PubMed ID: 12904931
[TBL] [Abstract][Full Text] [Related]
27. In vitro evaluation of the interaction potential of irosustat with drug-metabolizing enzymes.
Ventura V; Solà J; Peraire C; Brée F; Obach R
Drug Metab Dispos; 2012 Jul; 40(7):1268-78. PubMed ID: 22451700
[TBL] [Abstract][Full Text] [Related]
28. Gestational age-dependent changes in gene expression of metabolic enzymes and transporters in pregnant mice.
Shuster DL; Bammler TK; Beyer RP; Macdonald JW; Tsai JM; Farin FM; Hebert MF; Thummel KE; Mao Q
Drug Metab Dispos; 2013 Feb; 41(2):332-42. PubMed ID: 23175668
[TBL] [Abstract][Full Text] [Related]
29. Ximelagatran, an oral direct thrombin inhibitor, has a low potential for cytochrome P450-mediated drug-drug interactions.
Bredberg E; Andersson TB; Frison L; Thuresson A; Johansson S; Eriksson-Lepkowska M; Larsson M; Eriksson UG
Clin Pharmacokinet; 2003; 42(8):765-77. PubMed ID: 12846597
[TBL] [Abstract][Full Text] [Related]
30. Pregnancy-related pharmacokinetic changes.
Tasnif Y; Morado J; Hebert MF
Clin Pharmacol Ther; 2016 Jul; 100(1):53-62. PubMed ID: 27082931
[TBL] [Abstract][Full Text] [Related]
31. Effect of honokiol on the induction of drug-metabolizing enzymes in human hepatocytes.
Cho YY; Jeong HU; Kim JH; Lee HS
Drug Des Devel Ther; 2014; 8():2137-45. PubMed ID: 25395831
[TBL] [Abstract][Full Text] [Related]
32. Humanized transgenic mouse models for drug metabolism and pharmacokinetic research.
Shen HW; Jiang XL; Gonzalez FJ; Yu AM
Curr Drug Metab; 2011 Dec; 12(10):997-1006. PubMed ID: 22023319
[TBL] [Abstract][Full Text] [Related]
33. Effect of colchicine on rat hepatic cytochrome P450 enzymes by cocktail probe drugs.
Xu BB; Xu ZS; Zheng SL; Tang CR
Pharmazie; 2014 Jan; 69(1):43-7. PubMed ID: 24601222
[TBL] [Abstract][Full Text] [Related]
34. Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?
Isoherranen N; Thummel KE
Drug Metab Dispos; 2013 Feb; 41(2):256-62. PubMed ID: 23328895
[TBL] [Abstract][Full Text] [Related]
35. Clinical pharmacokinetic profile of modafinil.
Robertson P; Hellriegel ET
Clin Pharmacokinet; 2003; 42(2):123-37. PubMed ID: 12537513
[TBL] [Abstract][Full Text] [Related]
36. Risk assessment of accidental nortriptyline poisoning: the importance of cytochrome P450 for nortriptyline elimination investigated using a population-based pharmacokinetic simulator.
Jornil J; Jensen KG; Larsen F; Linnet K
Eur J Pharm Sci; 2011 Oct; 44(3):265-72. PubMed ID: 21854846
[TBL] [Abstract][Full Text] [Related]
37. Alterations in drug disposition during pregnancy: implications for drug therapy.
Hodge LS; Tracy TS
Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):557-71. PubMed ID: 17696806
[TBL] [Abstract][Full Text] [Related]
38. Gender-related differences in pharmacokinetics and their clinical significance.
Tanaka E
J Clin Pharm Ther; 1999 Oct; 24(5):339-46. PubMed ID: 10583696
[TBL] [Abstract][Full Text] [Related]
39. Sex differences in drug metabolism: cytochrome P-450 and uridine diphosphate glucuronosyltransferase.
Anderson GD
J Gend Specif Med; 2002; 5(1):25-33. PubMed ID: 11859684
[TBL] [Abstract][Full Text] [Related]
40. Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor.
Davies NM; McLachlan AJ; Day RO; Williams KM
Clin Pharmacokinet; 2000 Mar; 38(3):225-42. PubMed ID: 10749518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
